In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.
from NYT > Health https://ift.tt/aIZJ93E
April Health and Fitness Tips weight loss health and wellness and tips
0 comments:
Post a Comment